Blogs

From February 10–13, 2026, healthcare innovators from across the world will gather at WHX Labs Dubai, held at the Dubai World Trade Centre. At Booth S1.D58, Ozelle will spotlight how AI-powered Complete Blood Morphology (CBM) and all-in-one diagnostics are reshaping everyday clinical practice, especially in decentralized and high-demand settings. A New Standard for Complete Blood […]

In an era where healthcare accessibility and efficiency define clinical success, diagnostic devices must adapt to increasingly diverse medical environments. From urban community clinics to rural health stations, diagnostic infrastructure remains a cornerstone of accurate, timely treatment. Yet, despite rapid technological progress, many medical institutions—especially those at the primary care level—still face major obstacles in

Laboratory diagnostic equipment has become a prime target for healthcare cybercriminals. Forescout’s 2025 risk analysis identifies laboratory diagnostic equipment—including blood and urine analyzers—as newly prominent high-risk devices in healthcare networks. A critical vulnerability persists: data exchanged between these analyzers and Laboratory Information Systems is often transmitted unencrypted, enabling patient data theft and diagnostic result tampering.

Procurement teams spend thousands analyzing analyzer specifications, yet 73% still choose 5-part systems as the “safe middle ground.” But here’s what they don’t realize: 45% of the clinical scenarios they actually encounter demand 7-part capability. This critical mismatch between purchasing decisions and diagnostic requirements creates blind spots in patient care, missed early diagnoses, and suboptimal

AI adoption in veterinary diagnostics is accelerating rapidly, with the global veterinary diagnostics market is projected to reach USD 5.36 billion by 2030, growing from USD 3.68 billion in 2025 (CAGR 7.8%). Yet a critical uncertainty persists among veterinary professionals: Does AI actually work as well for animal blood as human blood? The answer is

Executive Summary: Market Inflection Point India’s hematology diagnostics market is experiencing accelerated growth, expanding from USD 420 million in 2024 to USD 720 million in 2035, representing a compound annual growth rate of 5.0%. Beyond this, India’s overall diagnostic industry reaches USD 4-5 billion in scale with annual growth of 13-14%, yet the organized segment

Regulatory approval is essential but structurally different across the US and EU for CBC analyzer suppliers. The FDA’s 510(k) pathway and EU’s IVDR CE marking system employ distinct procedural architectures, evidence requirements, and governance models—not simply varying speeds for the same goal. FDA 510(k) achieves clearance via predicate-device equivalence in 4–12 months (if strong predicates

Healthcare data breaches cost an average of $7.42 million in 2025, with U.S. breaches averaging $10.22 million—67% higher than the global average. Alarmingly, 1.2 million internet-connected healthcare devices are publicly accessible online, including blood-test systems. Many healthcare organizations report managing IoT devices with known vulnerabilities. Compact hematology analyzers increasingly integrate with Laboratory Information Systems (LIS),

Introduction: The Foundation of Modern Diagnostics The Complete Blood Count (CBC) remains the most frequently ordered laboratory test in clinical practice worldwide. This comprehensive panel measures three fundamental cell populations—red blood cells, white blood cells, and platelets—providing clinicians with critical information for diagnosing infections, anemia, hemostasis disorders, and systemic diseases. Understanding CBC analysis, its parameters,